Stock Events

Stock Events

Agios Pharmaceuticals (8AP.F) Q2 2024 Earnings

2MayConfirmed

Q3 2023

Q4 2023

Q1 2024

Q2 2024

-1.6

-1.52

-1.43

-1.35

Details

Expected EPS

-1.528644

Actual EPS

-1.351545

Surprise EPS

0.18

Surprise Percent

+11.59%

Description

Agios Pharmaceuticals (8AP.F) has reported earnings of -1.351545 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.